Super‐Enhancer‐Mediated DLX5 Activation Defines Regulatory Mechanisms in Human Embryonic Stem Cell‐Derived Osteoblasts
Development, Growth & Differentiation · 2025
DOI: 10.1111/dgd.70023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Development, Growth & Differentiation, 2025. Verfasst von Shinse Fujita und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Biotechnology, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo,…. Hauptthemen laut MEDLINE: Osteoblasts, Enhancer Elements, Genetic, Human Embryonic Stem Cells, Homeodomain Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Science and Technology Agency, Nakatomi Foundation.
Abstract (Originalsprache)
Osteoblast differentiation is essential for skeletal development and homeostasis. Although bone marrow‐derived mesenchymal stem/stromal cells (BM‐MSCs) are commonly used to study osteoblast differentiation in the context of bone homeostasis, their relevance to osteoblast differentiation during human skeletal development remains unclear. To understand the regulatory mechanisms underlying osteoblast differentiation in a human developmental context, we performed Assay for Transposase‐Accessible Chromatin sequencing (ATAC‐seq) and RNA‐seq analyses on osteoblasts isolated from an in vivo implantation system using induced sclerotome derived from Col2.3‐GFP reporter human embryonic stem cells (hESCs). The resulting datasets revealed skeletal development‐associated chromatin accessibility and transcriptional profiles. Comparative analysis with BM‐MSC‐derived osteoblasts revealed that hESC‐derived osteoblasts were enriched for regulatory gene sets associated with ossification. Notably, we identified a super‐enhancer associated with DLX5 , a known osteoblast regulator, consisting of multiple cooperative enhancer elements to drive transcription. Taken together, this study provides a valuable resource for examining cis–trans regulatory mechanisms in human skeletal development and highlights DLX5 as a key transcriptional regulator controlled by an osteoblast super‐enhancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Clinical Biotechnology, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Orthopaedic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Children's Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Department of Tissue and Developmental Biology, Graduate School of Dentistry, The University of Osaka, Osaka, Japan.
- Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Shinse Fujita, Hironori Hojo
Förderung
- Japan Agency for Medical Research and Development
- Japan Science and Technology Agency
- Nakatomi Foundation
- Daiichi Sankyo Foundation of Life Science
- Terumo Foundation for Life Sciences and Arts
- Japan Society for the Promotion of Science
Zitieren
APA
Fujita, S., Tani, S., Okada, H., Saito, T., Tanaka, S., Ohba, S., Chung, U. I., & Hojo, H. (2025). Super‐Enhancer‐Mediated DLX5 Activation Defines Regulatory Mechanisms in Human Embryonic Stem Cell‐Derived Osteoblasts. Development, Growth & Differentiation. https://doi.org/10.1111/dgd.70023
Vancouver
Fujita S, Tani S, Okada H, Saito T, Tanaka S, Ohba S, et al. Super‐Enhancer‐Mediated DLX5 Activation Defines Regulatory Mechanisms in Human Embryonic Stem Cell‐Derived Osteoblasts. Development, Growth & Differentiation. 2025. doi:10.1111/dgd.70023
BibTeX
@article{Fujita2025,
author = {Fujita, Shinse and Tani, Shoichiro and Okada, Hiroyuki and Saito, Taku and Tanaka, Sakae and Ohba, Shinsuke and Chung, Ung-Il and Hojo, Hironori},
title = {Super‐Enhancer‐Mediated DLX5 Activation Defines Regulatory Mechanisms in Human Embryonic Stem Cell‐Derived Osteoblasts},
journal = {Development, Growth & Differentiation},
year = {2025},
doi = {10.1111/dgd.70023}
}
EUVIMED